367 related articles for article (PubMed ID: 24365144)
1. Genetically redirected T lymphocytes for adoptive immunotherapy of solid tumors.
Leuci V; Mesiano G; Gammaitoni L; Aglietta M; Sangiolo D
Curr Gene Ther; 2014 Feb; 14(1):52-62. PubMed ID: 24365144
[TBL] [Abstract][Full Text] [Related]
2. Redirected T cells in cancer therapy.
Sangiolo D
Expert Opin Biol Ther; 2015; 15(12):1667-70. PubMed ID: 26515608
[TBL] [Abstract][Full Text] [Related]
3. Strategies to improve the clinical performance of chimeric antigen receptor-modified T cells for cancer.
Zhang Q; Li H; Yang J; Li L; Zhang B; Li J; Zheng J
Curr Gene Ther; 2013 Feb; 13(1):65-70. PubMed ID: 23256743
[TBL] [Abstract][Full Text] [Related]
4. The weal and woe of costimulation in the adoptive therapy of cancer with chimeric antigen receptor (CAR)-redirected T cells.
Hombach AA; Holzinger A; Abken H
Curr Mol Med; 2013 Aug; 13(7):1079-88. PubMed ID: 23116267
[TBL] [Abstract][Full Text] [Related]
5. Functional design of chimeric T-cell antigen receptors for adoptive immunotherapy of cancer: architecture and outcomes.
Shirasu N; Kuroki M
Anticancer Res; 2012 Jun; 32(6):2377-83. PubMed ID: 22641678
[TBL] [Abstract][Full Text] [Related]
6. Hurdles of CAR-T cell-based cancer immunotherapy directed against solid tumors.
Zhang BL; Qin DY; Mo ZM; Li Y; Wei W; Wang YS; Wang W; Wei YQ
Sci China Life Sci; 2016 Apr; 59(4):340-8. PubMed ID: 26965525
[TBL] [Abstract][Full Text] [Related]
7. Treatment of solid tumors with chimeric antigen receptor-engineered T cells: current status and future prospects.
Di S; Li Z
Sci China Life Sci; 2016 Apr; 59(4):360-9. PubMed ID: 26968709
[TBL] [Abstract][Full Text] [Related]
8. Rebalancing immune specificity and function in cancer by T-cell receptor gene therapy.
Udyavar A; Geiger TL
Arch Immunol Ther Exp (Warsz); 2010 Oct; 58(5):335-46. PubMed ID: 20680493
[TBL] [Abstract][Full Text] [Related]
9. Chimeric T cells for adoptive immunotherapy of cancer: using what have we learned to plan for the future.
Peinert S; Kershaw MH; Prince HM
Immunotherapy; 2009 Nov; 1(6):905-12. PubMed ID: 20635906
[No Abstract] [Full Text] [Related]
10. Adoptive T-cell immunotherapy of cancer using chimeric antigen receptor-grafted T cells.
Davies DM; Maher J
Arch Immunol Ther Exp (Warsz); 2010 Jun; 58(3):165-78. PubMed ID: 20373147
[TBL] [Abstract][Full Text] [Related]
11. Chimeric antigen receptors for T cell immunotherapy: current understanding and future directions.
Curran KJ; Pegram HJ; Brentjens RJ
J Gene Med; 2012 Jun; 14(6):405-15. PubMed ID: 22262649
[TBL] [Abstract][Full Text] [Related]
12. Treating cancer with genetically engineered T cells.
Park TS; Rosenberg SA; Morgan RA
Trends Biotechnol; 2011 Nov; 29(11):550-7. PubMed ID: 21663987
[TBL] [Abstract][Full Text] [Related]
13. Life or death of T cells with antigen-specific receptors--using T cells for cancer adoptive immunotherapy/gene therapy.
Ren-Heidenreich L; Lum LG
Curr Gene Ther; 2001 Sep; 1(3):253-5. PubMed ID: 12109140
[TBL] [Abstract][Full Text] [Related]
14. Current status and regulatory perspective of chimeric antigen receptor-modified T cell therapeutics.
Kim MG; Kim D; Suh SK; Park Z; Choi MJ; Oh YK
Arch Pharm Res; 2016 Apr; 39(4):437-452. PubMed ID: 26895243
[TBL] [Abstract][Full Text] [Related]
15. TCR-like CARs and TCR-CARs targeting neoepitopes: an emerging potential.
Poorebrahim M; Mohammadkhani N; Mahmoudi R; Gholizadeh M; Fakhr E; Cid-Arregui A
Cancer Gene Ther; 2021 Jun; 28(6):581-589. PubMed ID: 33654227
[TBL] [Abstract][Full Text] [Related]
16. Chimeric antigen receptor-redirected T cells return to the bench.
Geldres C; Savoldo B; Dotti G
Semin Immunol; 2016 Feb; 28(1):3-9. PubMed ID: 26797495
[TBL] [Abstract][Full Text] [Related]
17. Establishing guidelines for CAR-T cells: challenges and considerations.
Wang W; Qin DY; Zhang BL; Wei W; Wang YS; Wei YQ
Sci China Life Sci; 2016 Apr; 59(4):333-9. PubMed ID: 26965523
[TBL] [Abstract][Full Text] [Related]
18. Moving from tinkering in the garage to assembly line production: the manufacture of genetically modified T cells expressing chimeric antigen receptors (CARs) comes on line.
Cooper LJ
Cancer Gene Ther; 2015 Mar; 22(2):64-6. PubMed ID: 25675874
[No Abstract] [Full Text] [Related]
19. Chimeric antigen receptor engineering: a right step in the evolution of adoptive cellular immunotherapy.
Figueroa JA; Reidy A; Mirandola L; Trotter K; Suvorava N; Figueroa A; Konala V; Aulakh A; Littlefield L; Grizzi F; Rahman RL; Jenkins MR; Musgrove B; Radhi S; D'Cunha N; D'Cunha LN; Hermonat PL; Cobos E; Chiriva-Internati M
Int Rev Immunol; 2015 Mar; 34(2):154-87. PubMed ID: 25901860
[TBL] [Abstract][Full Text] [Related]
20. Spotlight on chimeric antigen receptor engineered T cell research and clinical trials in China.
Luo C; Wei J; Han W
Sci China Life Sci; 2016 Apr; 59(4):349-59. PubMed ID: 27009301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
